United States Antimony (UAMY) 10-Q 14 Aug 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Aug. 14, 2019
Document And Entity Information
Entity Registrant Name	UNITED STATES ANTIMONY CORP
Entity Central Index Key	0000101538
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		68,757,354
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2019

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 45,762	$ 56,650
Certificates of deposit	253,552	252,954
Accounts receivable, net	417,005	438,391
Inventories	723,688	755,261
Note receivable - sale of land	0	400,000
Total current assets	1,440,007	1,903,256
Properties, plants and equipment, net	15,254,204	15,227,172
Restricted cash for reclamation bonds	57,247	57,247
IVA receivable and other assets	367,769	369,448
Total assets	17,119,227	17,557,123
Current liabilities:
Checks issued and payable	113,028	46,482
Accounts payable	2,071,572	1,926,320
Due to factor	13,804	16,524
Accrued payroll, taxes and interest	241,882	159,037
Other accrued liabilities	389,693	353,911
Payables to related party	356,902	93,567
Deferred revenue	32,400	32,400
Notes payable to bank	199,998	183,917
Long-term debt, current portion, net of discount	761,663	705,460
Total current liabilities	4,180,942	3,517,618
Long-term debt, net of discount and current portion	918,435	1,027,730
Hillgrove advances payable	1,134,221	1,134,221
Stock payable to directors for services	62,500	175,000
Asset retirement obligations and accrued reclamation costs	280,794	277,720
Total liabilities	6,576,892	6,132,289
Commitments and contingencies (Note 7)
Stockholders' equity:
Common stock, $0.01 par value, 90,000,000 shares authorized; 68,757,354 and 68,227,171 shares issued and outstanding, respectively	687,573	682,271
Additional paid-in capital	36,712,572	36,406,874
Accumulated deficit	(26,884,598)	(25,691,099)
Total stockholders' equity	10,542,335	11,424,834
Total liabilities and stockholders' equity	17,119,227	17,557,123
Series A
Stockholders' equity:
Preferred stock $0.01 par value, 10,000,000 shares authorized	0	0
Series B
Stockholders' equity:
Preferred stock $0.01 par value, 10,000,000 shares authorized	7,500	7,500
Series C
Stockholders' equity:
Preferred stock $0.01 par value, 10,000,000 shares authorized	1,779	1,779
Series D
Stockholders' equity:
Preferred stock $0.01 par value, 10,000,000 shares authorized	$ 17,509	$ 17,509

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Stockholders' equity:
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized shares	90,000,000	90,000,000
Common stock, issued shares	68,757,354	68,227,171
Common stock, outstanding shares	68,757,354	68,227,171
Series A
Stockholders' equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Series B
Stockholders' equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	750,000	750,000
Preferred stock, outstanding shares	750,000	750,000
Preferred stock liquidation preference	$ 930,000	$ 922,500
Series C
Stockholders' equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	177,904	177,904
Preferred stock, outstanding shares	177,904	177,904
Preferred stock liquidation preference	$ 97,847	$ 97,847
Series D
Stockholders' equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	1,751,005	1,751,005
Preferred stock, outstanding shares	1,751,005	1,751,005
Preferred stock liquidation preference	$ 5,002,470	$ 4,961,324

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
REVENUES	$ 2,272,283	$ 2,256,347	$ 4,728,648	$ 4,689,276
COST OF REVENUES	2,445,478	2,114,999	4,970,896	4,603,016
GROSS PROFIT (LOSS)	(173,195)	141,348	(242,248)	86,260
OPERATING EXPENSES:
General and administrative	153,909	186,411	359,083	337,242
Salaries and benefits	100,362	96,427	333,030	187,873
Other operating expenses	10,500	0	86,630	0
Professional fees	22,452	18,563	123,194	120,967
TOTAL OPERATING EXPENSES	287,223	301,401	901,937	646,082
INCOME (LOSS) FROM OPERATIONS	(460,418)	(160,053)	(1,144,185)	(559,822)
OTHER INCOME (EXPENSE):
Interest income	31	268	772	830
Interest expense	(24,228)	(24,814)	(46,716)	(48,647)
Foreign exchange gain (loss)	0	62,752	0	12,752
Factoring expense	(1,424)	(938)	(3,370)	(2,338)
TOTAL OTHER INCOME (EXPENSE)	(25,621)	37,268	(49,314)	(37,403)
NET LOSS	$ (486,039)	$ (122,785)	$ (1,193,499)	$ (597,225)
Preferred dividends	$ (12,162)	$ (12,162)	$ (24,325)	$ (24,325)
Net loss available to common stockholders	$ (498,201)	$ (134,947)	$ (1,217,824)	$ (621,550)
Net income (loss) per share of common stock:
Basic	$ (0.01)	$ 0	$ (0.02)	$ (0.01)
Diluted	$ (0.01)	$ 0	$ (0.02)	$ (0.01)
Weighted average shares outstanding:
Basic	68,721,070	67,959,175	68,614,804	67,724,965
Diluted	68,721,070	67,959,175	68,613,804	67,724,965

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning Balance, Shares at Dec. 31, 2017	2,678,909	67,488,153
Beginning Balance, Amount at Dec. 31, 2017	$ 26,788	$ 674,881	$ 36,239,264	$ (26,564,324)	$ 10,376,609
Issuance of common stock to chief financial officer, Shares		739,018
Issuance of common stock to chief financial officer, Amount		$ 7,390	167,610		175,000
Net income (loss)				(597,225)	(597,225)
Ending Balance, Shares at Jun. 30, 2018	2,678,909	68,227,171
Ending Balance, Amount at Jun. 30, 2018	$ 26,788	$ 682,271	36,406,874	(27,161,549)	9,954,384
Beginning Balance, Shares at Mar. 31, 2018	2,678,909	67,488,153
Beginning Balance, Amount at Mar. 31, 2018	$ 26,788	$ 674,881	36,239,264	(27,038,764)	9,902,169
Issuance of common stock to Directors, Shares		739,018
Issuance of common stock to Directors, Amount		$ 7,390	167,610		175,000
Net income (loss)				(122,785)	(122,785)
Ending Balance, Shares at Jun. 30, 2018	2,678,909	68,227,171
Ending Balance, Amount at Jun. 30, 2018	$ 26,788	$ 682,271	36,406,874	(27,161,549)	9,954,384
Beginning Balance, Shares at Dec. 31, 2018	2,678,909	68,227,171
Beginning Balance, Amount at Dec. 31, 2018	$ 26,788	$ 682,271	36,406,874	(25,691,099)	11,424,834
Issuance of common stock to chief financial officer, Shares		200,000
Issuance of common stock to chief financial officer, Amount		$ 2,000	134,000		136,000
Issuance of common stock to Directors, Shares		330,183
Issuance of common stock to Directors, Amount		$ 3,302	171,698		175,000
Net income (loss)				(1,193,499)	(1,193,499)
Ending Balance, Shares at Jun. 30, 2019	2,678,909	68,757,354
Ending Balance, Amount at Jun. 30, 2019	$ 26,788	$ 687,573	36,712,572	(26,884,598)	10,542,335
Beginning Balance, Shares at Mar. 31, 2019	2,678,909	68,427,171
Beginning Balance, Amount at Mar. 31, 2019	$ 26,788	$ 684,271	36,540,874	(26,398,559)	10,853,374
Issuance of common stock to Directors, Shares		330,183
Issuance of common stock to Directors, Amount		$ 3,302	171,698		175,000
Net income (loss)				(486,039)	(486,039)
Ending Balance, Shares at Jun. 30, 2019	2,678,909	68,757,354
Ending Balance, Amount at Jun. 30, 2019	$ 26,788	$ 687,573	$ 36,712,572	$ (26,884,598)	$ 10,542,335

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash Flows From Operating Activities:
Net income (loss)	$ (1,193,499)	$ (597,225)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization	446,546	452,659
Amortization of debt discount	36,338	42,240
Accretion of asset retirement obligation	3,074	3,074
Common stock issued for services	136,000	0
Common stock payable for directors fees	62,500	87,500
Foreign exchange (gain) loss	0	(12,752)
Other non cash items	(598)	(656)
Change in:
Accounts receivable	21,386	(98,712)
Inventories	31,573	202,013
Other current assets	0	4,697
Other assets	1,679	(11,935)
Accounts payable	145,252	91,299
Accrued payroll, taxes and interest	82,845	26,420
Deferred revenue	0	(27,649)
Other accrued liabilities	35,782	36,834
Payables to related party	36,135	10
Net cash provided (used) by operating activities	(154,987)	197,817
Cash Flows From Investing Activities:
Payment received on note receivable - sale of land	400,000
Purchase of properties, plants and equipment	(473,578)	(174,388)
Net cash used by investing activities	(73,578)	(174,388)
Cash Flows From Financing Activities:
Change in checks issued and payable	66,546	82,330
Net proceeds from (payments to) factor	(2,720)	(5,440)
Advance from related party	227,200	75,000
Payment on advances from related party	0	(75,000)
Proceeds from notes payable to bank	16,081	0
Principal paid on notes payable to bank	0	(1,556)
Principal payments on long-term debt	(89,430)	(110,872)
Net cash provided (used) by financing activities	217,677	(35,538)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	(10,888)	(12,109)
Cash and cash equivalents and restricted cash at beginning of period	113,897	91,332
Cash and cash equivalents and restricted cash at end of period	103,009	79,223
Noncash investing and financing activities:
Common stock payable issued to directors	$ 175,000	$ 175,000

1. Basis of Presentation

1. Basis of Presentation	6 Months Ended
	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America for interim financial information, as well as the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of the Company’s management, all adjustments (consisting of only normal recurring accruals) considered necessary for a fair presentation of the interim financial statements have been included. Operating results for the three and six month periods ended June 30, 2019 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2019. For further information refer to the financial statements and footnotes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Going Concern Consideration At June 30, 2019, the Company’s consolidated financial statements show negative working capital of approximately $2.7 million and accumulated deficit of approximately $26.9 million. In addition, the Company has a net loss of $1,193,499 for the six month period ended June 30, 2019, and the Company has had recurring operating losses for most of the prior periods. These factors indicate that there may be doubt regarding the ability to continue as a going concern for the next twelve months. The continuing losses are principally a result of the falling prices of antimony and the Company’s antimony operations and production costs incurred in Mexico. Regarding the antimony division, prices decreased approximately 13% in the first six months of 2019 compared to the same period in the prior year. For the six months ended June 30, 2019, the average sale price for antimony was approximately $3.73 per pound compared to a price of $4.28 per pound for the six months ended June 30, 2018. During 2018, we endured supply interruptions from our North American supplier, but shipments have resumed, although at a lower level than years prior to 2018. A new supply agreement negotiated with our North American supplier in 2017 has helped us with cash flow from our antimony division in 2018, but falling prices for antimony have caused us to see a need for a better supply agreement in 2019. In 2017, we reduced costs for labor at the Mexico locations which has resulted in a lower overall production costs in Mexico and we adjusted operating approaches at Madero that resulted in decreased operating costs for fuel, natural gas, electricity, and reagents for 2018 and 2019. In June of 2019, we again reached agreement with our miners in Mexico to reduce labor costs, and we completed installation of one of the large rotating furnaces (LRFs) we obtained from the Lanxess transaction, which has resulted in lower operating costs. The Company’s 2019 plan involves ramping up production at our antimony properties in Mexico, and installing additional LRFs obtained from Lanxess. Our expectations are that in the second half of 2019 we can substantially increase the antimony output from our Mexican properties from the 2018 production. We are producing and selling antimony metal directly from Mexico to customers which will save us approximately $0.38 per pound in processing costs and freight. In addition, a new leach circuit expected to come on line during 2019 in Mexico will result in more extraction of precious metals. The portion of the precious metals recovery system at the Madero smelter is complete and the cyanide leach circuit being built at the Puerto Blanco plant is expected to be completed and tested in the third quarter of 2019. We expect to be receiving income from the production of precious metals some time during the third quarter of 2019. We believe that with the lower cost per pound due to increased production and the savings from shipping metal directly from Mexico, we will have positive cash flow for Mexican antimony production by the end of the year and that we will be selling precious metals produced from Los Juarez before the end of 2019. Our orders for antimony were slow during the latter part of the second quarter of 2019, which we believe was caused by the uncertainties of trade with China. Over the past several years, the Company has been able to make required principal payments on its debt from cash generated from operations without the need for additional borrowings or selling shares of its common stock. The Company plans to continue keeping current on its debt payments in 2019 through cash flows from operations while we continue with the expansion of our Mexican operation. As of August 14, 2019, we have received payment and are in the process of completing a common stock private placement for $444,160 to complete the precious metals circuit at our Puerto Blanco milling facility, and to make cost saving repairs at our Montana smelter. Management believes that the actions taken to increase our capital, and to increase production and revenue from both antimony and precious metals, along with a reduction in production costs, will enable the Company to meet its obligations for the next twelve months.

2. Developments in Accounting P

2. Developments in Accounting Pronouncements	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
Developments in Accounting Pronouncements	Accounting Standards Updates Adopted In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02 Leases (Topic 842). The update modified the classification criteria and requires lessees to recognize the assets and liabilities on the balance sheet for most leases. The update was effective for fiscal years beginning after December 15, 2018, with early adoption permitted. Adoption of this update as of January 1, 2019 did not have a material impact on the Company’s consolidated financial statements. In June 2018, the FASB issued ASU No. 2018-07 Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. The update involves simplification of several aspects of accounting for nonemployee share-based payment transactions by expanding the scope of Topic 718 to include nonemployee awards. The update was effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. Adoption of this update as of January 1, 2019 did not have a material impact on the Company’s consolidated financial statements. Accounting Standards Updates to Become Effective in Future Periods In August 2018, the FASB issued ASU No. 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The update removes, modifies and makes additions to the disclosure requirements on fair value measurements. The update is effective for fiscal years beginning after December 15, 2019, with early adoption permitted. Management is evaluating the impact of this update on the Company’s fair value measurement disclosures.

3. Income (Loss) Per Common Sha

3. Income (Loss) Per Common Share	6 Months Ended
	Jun. 30, 2019
Net income (loss) per share of common stock:
Income (Loss) Per Common Share	Basic earnings per share is calculated by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including warrants to purchase the Company's common stock and convertible preferred stock. For the three and six months ended June 30, 2019 and 2018, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive are as follows: June 30, 2019 June 30, 2018 Warrants 250,000 250,000 Convertible preferred stock 1,751,005 1,751,005 Total possible dilution 2,001,005 2,001,005

4. Revenue Recognition

4. Revenue Recognition	6 Months Ended
	Jun. 30, 2019
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Our products consist of the following: ● Antimony: includes antimony oxide, sodium antimonate, antimony trisulfide, and antimony metal ● Zeolite: includes coarse and fine zeolite crushed in various sizes ● Precious Metals: includes unrefined and refined gold and silver For our antimony and zeolite products, revenue is recognized upon the completion of the performance obligation which is met when the transaction price can be reasonably estimated and revenue is recognized generally at the time when risk is transferred. We have determined the performance obligation is met and title is transferred either upon shipment from our warehouse locations or upon receipt by the customer as specified in individual sales orders. The performance obligation is met because at that time, 1) legal title is transferred to the customer, 2) the customer has accepted the product and obtained the ability to realize all of the benefits from the product, 3) the customer has the significant risks and rewards of ownership to it, 4) it is very unlikely product will be rejected by the customer upon physical receipt, and 5) we have the right to payment for the product. Shipping costs related to the sales of antimony and zeolite products are recorded to cost of sales as incurred. For zeolite products, royalty expense due a third party by the Company is also recorded to cost of sales upon sale in accordance with terms of underlying royalty agreements. For sales of precious metals, the performance obligation is met, the transaction price is known, and revenue is recognized at the time of transfer of control of the agreed-upon metal quantities to the customer. Refining and shipping costs related to sales of precious metals are recorded to cost of sales as incurred. Sales of products for the three and six month periods ended June 30, 2019 and 2018 were as follows: Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Antimony $ 1,507,588 $ 1,492,520 $ 3,213,411 $ 3,174,333 Zeolite 704,172 682,534 1,430,187 1,373,240 Precious metals 60,523 81,293 85,050 141,703 $ 2,272,283 $ 2,256,347 $ 4,728,648 $ 4,689,276 The following is sales information by geographic area based on the location of customers for the three and six-month periods ended June 30, 2019 and 2018: Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 United States $ 1,819,707 $ 1,878,244 $ 3,928,276 $ 4,125,935 Canada 139,523 378,103 326,780 563,341 Mexico 313,053 - 473,592 - $ 2,272,283 $ 2,256,347 $ 4,728,648 $ 4,689,276 Sales of products to significant customers were as follows for the three and six month periods ended June 30, 2019 and 2018: For the Three Months Ended For the Six Months Ended June 30, 2019 June 30, 2018 June 30, 2019 June 30, 2018 Mexichem Speciality Compounds $ 375,514 $ 669,103 $ 1,059,525 $ 1,397,681 Nyacol Nanotechnologies 267,638 - 404,324 - Kohler Corporation 454,943 334,778 913,037 651,550 Ampacet Corporation - - - 330,260 ZEO, Inc. - 185,730 - - $ 1,098,095 $ 1,189,611 $ 2,376,886 $ 2,379,491 % of Total Revenues 48.33 % 52.70 % 50.27 % 50.70 % Accounts receivable from largest customers were as follows for June 30, 2019 and December 31, 2018: Accounts Receivable June 30, 2019 December 31, 2018 DanaMart $ - $ 143,890 Axens North America Inc. 25,121 34,912 Earth Innovations Inc. - 35,967 Kohler 123,106 - Nutreco Canada Inc. 27,963 - $ 176,190 $ 214,769 % of Total Receivables 42.25 % 49.00 % Our trade accounts receivable balance related to contracts with customers was $417,005 at June 30, 2019 and $438,391 at December 31, 2018. Our products do not involve any warranty agreements and product returns are not typical. We have determined our contracts do not include a significant financing component. For antimony and zeolite sales contracts, we may factor certain receivables and receive final payment within 30 days of the performance obligation being met. For antimony and zeolite receivables not factored, we typically receive payment within 10 days. For precious metals sales, a provisional payment of 75% is typically received within 45 days of the date the product is delivered to the customer. After an exchange of assays, a final payment is normally received within 90 days of product delivery.

5. Inventories

5. Inventories	6 Months Ended
	Jun. 30, 2019
Inventory Disclosure [Abstract]
Inventories	Inventories at June 30, 2019 and December 31, 2018 consisted primarily of finished antimony products, antimony metal, antimony ore, and finished zeolite products that are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products, antimony metal and finished zeolite products costs include raw materials, direct labor and processing facility overhead costs and freight. Inventory at June 30, 2019 and December 31, 2018 is as follows: June 30, December 31, 2019 2018 Antimony Metal $ - $ 8,127 Antimony Oxide 252,128 255,782 Antimony Concentrates - 2,214 Antimony Ore 201,543 257,067 Total antimony 453,671 523,190 Zeolite 270,017 232,071 $ 723,688 $ 755,261

6. Accounts Receivable and Due

6. Accounts Receivable and Due to Factor	6 Months Ended
	Jun. 30, 2019
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Accounts Receivable and Due to Factor	The Company factors designated trade receivables pursuant to a factoring agreement with LSQ Funding Group L.C., an unrelated factor (the “Factor”). The agreement specifies that eligible trade receivables are factored with recourse. We submit selected trade receivables to the factor, and receive 83% of the face value of the receivable by wire transfer. The Factor withholds 15% as retainage, and 2% as a servicing fee. Upon payment by the customer, we receive the remainder of the amount due from the factor. The 2% servicing fee is recorded on the consolidated statement of operations in the period of sale to the factor. John Lawrence, CEO, is a personal guarantor of the amount due to Factor. Trade receivables assigned to the Factor are carried at the original invoice amount less an estimate made for doubtful accounts. Under the terms of the recourse provision, the Company is required to reimburse the Factor, upon demand, for factored receivables that are not paid on time. Accordingly, these receivables are accounted for as a secured financing arrangement and not as a sale of financial assets. The allowance for doubtful accounts (if any) is based on management’s regular evaluation of individual customer’s receivables and consideration of a customer’s financial condition and credit history. Trade receivables are written off when deemed uncollectible. Recoveries of trade receivables previously written off are recorded when received. Interest is not charged on past due accounts. We present the receivables, net of allowances, as current assets and we present the amount potentially due to the Factor as a secured financing in current liabilities. Accounts Receivble June 30, 2019 December 31, 2018 Accounts receivable - non factored $ 403,201 $ 421,867 Accounts receivable - factored with recourse 13,804 16,524 Accounts receivable - net $ 417,005 $ 438,391

7. Commitments and Contingencie

7. Commitments and Contingencies	6 Months Ended
	Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	In June of 2013, the Company entered into a lease to mine antimony ore from concessions located in the Wadley Mining district in Mexico. The lease calls for a term of one year and, as of June 30, 2019, requires payments of $10,000 plus a tax of $1,700, per month. The lease is renewable each year with a 15 day notice to the lessor, and agreement of terms. The next lease is scheduled for renewal in June 2020.

8. Note Payable to Bank

8. Note Payable to Bank	6 Months Ended
	Jun. 30, 2019
Notes Payable [Abstract]
Note Payable to Bank	At June 30, 2019 and December 31, 2018, the Company had the following notes payable to bank: June 30, December 31, 2019 2018 Promissory note payable to First Security Bank of Missoula, bearing interest at 3.150%, payable on demand, collateralized by a lien on Certificate of Deposit $ 99,999 $ 83,918 Promissory note payable to First Security Bank of Missoula, bearing interest at 3.150%, payable on demand, collateralized by a lien on Certificate of Deposit 99,999 99,999 Total notes payable to the bank $ 199,998 $ 183,917 These notes are personally guaranteed by John C. Lawrence the Company’s Chief Executive Officer and Chairman of the Board of Directors. The maximum amount available for borrowing under each note is $99,999.

9. Debt

9. Debt	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
Debt	Long-Term debt at Jume 30, 2019 and December 31, 2018 is as follows: June 30, December 31, 2019 2018 Note payable to Zeo Inc., non interest bearing, payable in 11 quarterly installments of $8,300 with a final payment of $8,700; (1) maturing December 2022; uncollateralized. $ 100,000 $ 100,000 Note payable to Cat Financial Services, bearing interest at 6%; payable in monthly installments of $1,300; maturing August 2019; collateralized by equipment. 5,321 14,022 Note payable to Cat Financial Services, bearing interest at 6%; payable in monthly installments of $778; maturing December 2022; collateralized by equipment. 30,071 34,390 Note payable to De Lage Landen Financial Services, bearing interest at 3.51%; payable in monthly installments of $655; maturing September 2019; collateralized by equipment. 2,005 5,851 Note payable to De Lage Landen Financial Services, bearing interest at 3.51%; payable in monthly installments of $655; maturing December 2019; collateralized by equipment. 4,569 8,371 Note payable to Phyllis Rice, bearing interest at 1%; payable in monthly installments of $2,000; originally maturing March 2015; collateralized by equipment. 6,146 12,146 Obligation payable for Soyatal Mine, non-interest bearing, annual payments of $100,000 or $200,000 through 2020, net of discount of $19,156 and $23,321, respectively. (2) 618,078 639,747 Obligation payable for Guadalupe Mine, non-interest bearing, annual payments from $60,000 to $149,078 through 2026, net of discount of $238,572 and $252,444, respectively. (3) 913,908 918,663 1,680,098 1,733,190 Less current portion (761,663 ) (705,460 ) Long-term portion $ 918,435 $ 1,027,730 (1) Payments starting the fourth quarter of 2019. (2) At June 30, 2019, the Company has not made $432,069 of principal payments due in previous periods on this note. At June 30, 2019, all but $47,619 of the balance is classified as a current liability. The creditor has agreed to accept payments of $2,500 USD per month through June 30, 2020, at which time the parties may agree to an extension of that payment schedule, or modify the payment schedule. The note holder has accepted, and was paid, $7,500 USD as payment for the months of April, May, and June of 2019 (3) At June 30, 2019, the Company is delinquent in $59,308 of principal payments on this note . At June 30, 2019, the delinquent balance is classified as a current liability. The Company is currently working with the lenders to modify the payment terms to cure the delinquent status. The Company has not received notice from the lenders indicating default on the loan. At June 30, 2019, principal payments on debt are due as follows: 12 Months Ending June 30, Principal Payment Discount Net 2020 $ 824,100 $ (62,437 ) $ 761,663 2021 240,956 (48,238 ) 192,718 2022 191,009 (39,188 ) 151,821 2023 179,735 (32,594 ) 147,141 2024 149,077 (25,605 ) 123,472 Thereafter 333,912 (30,629 ) 303,283 $ 1,918,789 $ (238,691 ) $ 1,680,098

10. Related Party Transactions

10. Related Party Transactions	6 Months Ended
	Jun. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	During the three and six months ended June 30, 2018, the Chairman of the audit committee and compensation committee received $4,500, and $9,000, respectively, for services performed. No compensation was received during the three and six month periods ended June 30, 2019. See Note 12 for shares of common stock issued to directors. For the three and six months ended June 30, 2019, the Company paid $3,480 and $2,461, respectively, compared to $5,064, and $4,555 for the three and six months ended June 30, 2018, to John Lawrence, our President and Chief Executive Officer, as reimbursement for equipment used by the Company. Mr. Lawrence advanced the Company $227,200 for ongoing operating expenses during the six months ended June 30, 2019. In addition to the loan that was owed to Mr. Lawrence at June 30, 2019, the Company also owed Mr. Lawrence for payroll and other liabilities equal to $129,702 for a total owed to Mr. Lawrence at June 30, 2019 of $356,902.

11. Income Taxes

11. Income Taxes	6 Months Ended
	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	During the three and six months ended June 30, 2019, and the year ended December 31, 2018, the Company determined that a valuation allowance equal to 100% of any deferred tax asset was appropriate, as management of the Company cannot determine that it is more likely than not the Company will realize the benefit of its net deferred tax asset. The net effect is that the deferred tax asset is fully reserved for at June 30, 2019 and December 31, 2018. Management estimates the effective tax rate at 0% for the current year.

12. Stockholder's Equity

12. Stockholder's Equity	6 Months Ended
	Jun. 30, 2019
Stockholders' equity:
Stockholder's Equity	Issuance of Common Stock for Payable to Board of Directors During the six month period ended June 30, 2019, the Board of Directors was issued a total of 330,183 shares of common stock for $175,000 in directors’ fees that were payable at December 31, 2018. In addition, during the three and six months ended June 30, 2019, the Company accrued $31,250 and $62,500, respectively, in directors’ fees payable that will be paid in common stock. In January 2019, the Company issued Daniel Parks, the Company’s Chief Financial Officer, 200,000 shares of the Company’s common stock with a fair value of $136,000 to retain his services. As part of the agreement, Mr. Parks’ hours worked and financial compensation were reduced. On May 3, 2018, the Board of Directors was issued a total of 739,018 shares of common stock for $175,000 in directors’ fees that were payable at December 31, 2017. In addition during the quarter and six months ended June 30, 2018, the Company accrued $43,750 and $87,500, respectively, in directors’ fees payable that will be paid in common stock.

13. Plant Acquisition

13. Plant Acquisition	6 Months Ended
	Jun. 30, 2019
Business Combinations [Abstract]
Plant Acquisition	On August 31, 2018, the Company closed a Member Interest and Capital Share Agreement (the “Agreement”) with Great Lakes Chemical Corporation and Lanxess Holding Company US Inc., as the sellers, and the Company as the buyer. Under the Agreement, the Company acquired a subsidiary of the sellers which includes an antimony plant, equipment and land located in Reynosa, Mexico. The Company disassembed, salvaged and transported the antimony plant and equipment for use in its existing operations in both Mexico and the United States. The project involved moving heavy equipment and was completed in the second quarter of 2019. In addition, the Company was paid $1,500,000 by the sellers, which was recognized as operating income in the quarter ended September 30, 2018, to assist in the salvage and transport costs of the useable equipment. The transaction was accounted for as an asset acquisition as there was no business associated with the acquired assets. The real property acquired with the plant was sold for $700,000 in November 2018, for which the Company received $300,000 in 2018 and the remaining balance of $400,000 in the three month period ended March 31, 2019.

14. Business Segments

14. Business Segments	6 Months Ended
	Jun. 30, 2019
Segment Reporting [Abstract]
Business Segments	The Company is currently organized and managed by four segments, which represent our operating units: United States antimony operations, Mexican antimony operations, precious metals recovery and United States zeolite operations. The Madero smelter and Puerto Blanco mill at the Company’s Mexico operation produces crude oxide and crude metal that is shipped to Montana for finishing at the Thompson Falls, Montana, plant, or finished antimony metal that is sold directly to customers in the United States. The precious metals recovery plant is operated in conjunction with the antimony processing plant at Thompson Falls, Montana. The zeolite operation produces zeolite near Preston, Idaho. Almost all of the sales of products from the United States antimony and zeolite operations are to customers in the United States. Segment disclosure regarding sales to major customers is located in Note 4. Properties, plants and equipment, net: June 30, 2019 December 31, 2018 Antimony United States $ 1,616,273 $ 1,635,315 Mexico 11,779,305 11,660,769 Subtotal Antimony 13,395,577 13,296,084 Precious metals 594,850 615,719 Zeolite 1,263,777 1,315,369 Total $ 15,254,204 $ 15,227,172 Total Assets: June 30, 2019 December 31, 2018 Antimony United States $ 2,171,811 $ 2,199,694 Mexico 12,453,537 12,824,292 Subtotal Antimony 14,625,348 15,023,986 Precious metals 594,850 615,719 Zeolite 1,899,029 1,917,418 Total $ 17,119,227 $ 17,557,123 For the Three Months Ended For the Six Months Ended June 30, 2019 June 30, 2018 June 30, 2019 June 30, 2018 Capital expenditures: Antimony United States $ 1,368 $ - $ 2,713 $ - Mexico 141,797 70,892 416,703 110,977 Subtotal Antimony 143,165 70,892 419,416 110,977 Precious Metals 6,398 - 13,152 40,988 Zeolite 11,447 8,691 41,010 22,423 Total $ 161,010 $ 79,583 $ 473,578 $ 174,388 Segment Operations for the three Antimony Antimony Total Precious months ended June 30, 2019 USA Mexico Antimony Metals Zeolite Totals Total revenues $ 1,194,535 $ 313,053 $ 1,507,588 $ 60,523 $ 704,172 $ 2,272,283 Depreciation and amortization $ 10,878 $ 149,083 $ 159,961 $ 17,011 $ 46,301 $ 223,273 Income (loss) from operations (56,245 ) (629,422 ) (685,667 ) 43,513 181,736 (460,418 ) Other income (expense): (4,420 ) (18,051 ) (22,471 ) - (3,150 ) (25,621 ) NET INCOME (LOSS) $ (60,665 ) $ (647,473 ) $ (708,138 ) $ 43,513 $ 178,586 $ (486,039 ) Segment Operations for the three Antimony Antimony Total Precious months ended June 30, 2018 USA Mexico Antimony Metals Zeolite Totals Total revenues $ 1,492,520 $ - $ 1,492,520 $ 81,293 $ 682,534 $ 2,256,347 Depreciation and amortization $ 13,170 $ 97,844 $ 111,014 $ 17,011 $ 47,072 $ 175,097 Income (loss) from operations 391,895 (808,575 ) (416,680 ) 114,801 141,826 (160,053 ) Other income (expense): (1,938 ) 41,630 39,692 - (2,424 ) 37,268 NET INCOME (LOSS) $ 389,957 $ (766,945 ) $ (376,988 ) $ 114,801 $ 139,402 $ (122,785 ) Segment Operations for the six Antimony Antimony Total Precious months ended June 30, 2019 USA Mexico Antimony Metals Zeolite Totals Total revenues $ 2,739,819 $ 473,592 $ 3,213,411 $ 85,050 $ 1,430,187 $ 4,728,648 Depreciation and amortization $ 21,755 $ 298,168 $ 319,923 $ 34,021 $ 92,602 $ 446,546 Income (loss) from operations (108,341 ) (1,432,098 ) (1,540,439 ) 51,029 345,225 (1,144,185 ) Other income (expense): (5,787 ) (36,338 ) (42,125 ) - (7,189 ) (49,314 ) NET INCOME (LOSS) $ (114,128 ) $ (1,468,436 ) $ (1,582,564 ) $ 51,029 $ 338,036 $ (1,193,499 ) Segment Operations for the six Antimony Antimony Total Precious months ended June 30, 2018 USA Mexico Antimony Metals Zeolite Totals Total revenues $ 3,174,333 $ - $ 3,174,333 $ 141,703 $ 1,373,240 $ 4,689,276 Depreciation and amortization $ 26,380 $ 297,366 $ 323,746 $ 34,021 $ 94,892 $ 452,659 Income (loss) from operations 589,934 (1,551,357 ) (961,423 ) 107,682 293,919 (559,822 ) Other income (expense): (2,716 ) (29,488 ) (32,204 ) - (5,199 ) (37,403 ) NET INCOME (LOSS) $ 587,218 $ (1,580,845 ) $ (993,627 ) $ 107,682 $ 288,720 $ (597,225 )

15. Subsequent Events

15. Subsequent Events	6 Months Ended
	Jun. 30, 2019
Subsequent Events [Abstract]
Subsequent Events	As of August 14, 2019, we are in the process of issuing approximately 925,333 shares of our common stock for $444,160. Each share includes one-half warrant to purchase one share of stock at $0.65 per share for three years from the date of issuance.

3. Income (Loss) Per Common S_2

3. Income (Loss) Per Common Share (Tables)	6 Months Ended
	Jun. 30, 2019
Net income (loss) per share of common stock:
Schedule of antidilutive securities excluded from computation of earnings per share	June 30, 2019 June 30, 2018 Warrants 250,000 250,000 Convertible preferred stock 1,751,005 1,751,005 Total possible dilution 2,001,005 2,001,005

4. Revenue Recognition (Tables)

4. Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2019
Revenue from Contract with Customer [Abstract]
Disaggregation of revenue	Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 Antimony $ 1,507,588 $ 1,492,520 $ 3,213,411 $ 3,174,333 Zeolite 704,172 682,534 1,430,187 1,373,240 Precious metals 60,523 81,293 85,050 141,703 $ 2,272,283 $ 2,256,347 $ 4,728,648 $ 4,689,276 Three Months Ended Six Months Ended June 30, June 30, 2019 2018 2019 2018 United States $ 1,819,707 $ 1,878,244 $ 3,928,276 $ 4,125,935 Canada 139,523 378,103 326,780 563,341 Mexico 313,053 - 473,592 - $ 2,272,283 $ 2,256,347 $ 4,728,648 $ 4,689,276
Sales of products to significant customers	Sales of products to significant customers were as follows for the three and six month periods ended June 30, 2019 and 2018: For the Three Months Ended For the Six Months Ended June 30, 2019 June 30, 2018 June 30, 2019 June 30, 2018 Mexichem Speciality Compounds $ 375,514 $ 669,103 $ 1,059,525 $ 1,397,681 Nyacol Nanotechnologies 267,638 - 404,324 - Kohler Corporation 454,943 334,778 913,037 651,550 Ampacet Corporation - - - 330,260 ZEO, Inc. - 185,730 - - $ 1,098,095 $ 1,189,611 $ 2,376,886 $ 2,379,491 % of Total Revenues 48.33 % 52.70 % 50.27 % 50.70 % Accounts receivable from largest customers were as follows for June 30, 2019 and December 31, 2018: Accounts Receivable June 30, 2019 December 31, 2018 DanaMart $ - $ 143,890 Axens North America Inc. 25,121 34,912 Earth Innovations Inc. - 35,967 Kohler 123,106 - Nutreco Canada Inc. 27,963 - $ 176,190 $ 214,769 % of Total Receivables 42.25 % 49.00 %

5. Inventories (Tables)

5. Inventories (Tables)	6 Months Ended
	Jun. 30, 2019
Inventory Disclosure [Abstract]
Inventories	June 30, December 31, 2019 2018 Antimony Metal $ - $ 8,127 Antimony Oxide 252,128 255,782 Antimony Concentrates - 2,214 Antimony Ore 201,543 257,067 Total antimony 453,671 523,190 Zeolite 270,017 232,071 $ 723,688 $ 755,261

6. Accounts Receivable and Du_2

6. Accounts Receivable and Due to Factor (Tables)	6 Months Ended
	Jun. 30, 2019
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Account receivables	Accounts Receivble June 30, 2019 December 31, 2018 Accounts receivable - non factored $ 403,201 $ 421,867 Accounts receivable - factored with recourse 13,804 16,524 Accounts receivable - net $ 417,005 $ 438,391

8. Note Payable to Bank (Tables

8. Note Payable to Bank (Tables)	6 Months Ended
	Jun. 30, 2019
Notes Payable [Abstract]
Summary of notes payable to bank	June 30, December 31, 2019 2018 Promissory note payable to First Security Bank of Missoula, bearing interest at 3.150%, payable on demand, collateralized by a lien on Certificate of Deposit $ 99,999 $ 83,918 Promissory note payable to First Security Bank of Missoula, bearing interest at 3.150%, payable on demand, collateralized by a lien on Certificate of Deposit 99,999 99,999 Total notes payable to the bank $ 199,998 $ 183,917

9. Debt (Tables)

9. Debt (Tables)	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
Long-term debt	Long-Term debt at Jume 30, 2019 and December 31, 2018 is as follows: June 30, December 31, 2019 2018 Note payable to Zeo Inc., non interest bearing, payable in 11 quarterly installments of $8,300 with a final payment of $8,700; (1) maturing December 2022; uncollateralized. $ 100,000 $ 100,000 Note payable to Cat Financial Services, bearing interest at 6%; payable in monthly installments of $1,300; maturing August 2019; collateralized by equipment. 5,321 14,022 Note payable to Cat Financial Services, bearing interest at 6%; payable in monthly installments of $778; maturing December 2022; collateralized by equipment. 30,071 34,390 Note payable to De Lage Landen Financial Services, bearing interest at 3.51%; payable in monthly installments of $655; maturing September 2019; collateralized by equipment. 2,005 5,851 Note payable to De Lage Landen Financial Services, bearing interest at 3.51%; payable in monthly installments of $655; maturing December 2019; collateralized by equipment. 4,569 8,371 Note payable to Phyllis Rice, bearing interest at 1%; payable in monthly installments of $2,000; originally maturing March 2015; collateralized by equipment. 6,146 12,146 Obligation payable for Soyatal Mine, non-interest bearing, annual payments of $100,000 or $200,000 through 2020, net of discount of $19,156 and $23,321, respectively. (2) 618,078 639,747 Obligation payable for Guadalupe Mine, non-interest bearing, annual payments from $60,000 to $149,078 through 2026, net of discount of $238,572 and $252,444, respectively. (3) 913,908 918,663 1,680,098 1,733,190 Less current portion (761,663 ) (705,460 ) Long-term portion $ 918,435 $ 1,027,730
Debt outstanding	12 Months Ending June 30, Principal Payment Discount Net 2020 $ 824,100 $ (62,437 ) $ 761,663 2021 240,956 (48,238 ) 192,718 2022 191,009 (39,188 ) 151,821 2023 179,735 (32,594 ) 147,141 2024 149,077 (25,605 ) 123,472 Thereafter 333,912 (30,629 ) 303,283 $ 1,918,789 $ (238,691 ) $ 1,680,098

13. Business Segments (Tables)

13. Business Segments (Tables)	6 Months Ended
	Jun. 30, 2019
Segment Reporting [Abstract]
Capital expenditure information	Properties, plants and equipment, net: June 30, 2019 December 31, 2018 Antimony United States $ 1,616,273 $ 1,635,315 Mexico 11,779,305 11,660,769 Subtotal Antimony 13,395,577 13,296,084 Precious metals 594,850 615,719 Zeolite 1,263,777 1,315,369 Total $ 15,254,204 $ 15,227,172 Total Assets: June 30, 2019 December 31, 2018 Antimony United States $ 2,171,811 $ 2,199,694 Mexico 12,453,537 12,824,292 Subtotal Antimony 14,625,348 15,023,986 Precious metals 594,850 615,719 Zeolite 1,899,029 1,917,418 Total $ 17,119,227 $ 17,557,123 For the Three Months Ended For the Six Months Ended June 30, 2019 June 30, 2018 June 30, 2019 June 30, 2018 Capital expenditures: Antimony United States $ 1,368 $ - $ 2,713 $ - Mexico 141,797 70,892 416,703 110,977 Subtotal Antimony 143,165 70,892 419,416 110,977 Precious Metals 6,398 - 13,152 40,988 Zeolite 11,447 8,691 41,010 22,423 Total $ 161,010 $ 79,583 $ 473,578 $ 174,388
Segment information	Segment Operations for the three Antimony Antimony Total Precious months ended June 30, 2019 USA Mexico Antimony Metals Zeolite Totals Total revenues $ 1,194,535 $ 313,053 $ 1,507,588 $ 60,523 $ 704,172 $ 2,272,283 Depreciation and amortization $ 10,878 $ 149,083 $ 159,961 $ 17,011 $ 46,301 $ 223,273 Income (loss) from operations (56,245 ) (629,422 ) (685,667 ) 43,513 181,736 (460,418 ) Other income (expense): (4,420 ) (18,051 ) (22,471 ) - (3,150 ) (25,621 ) NET INCOME (LOSS) $ (60,665 ) $ (647,473 ) $ (708,138 ) $ 43,513 $ 178,586 $ (486,039 ) Segment Operations for the three Antimony Antimony Total Precious months ended June 30, 2018 USA Mexico Antimony Metals Zeolite Totals Total revenues $ 1,492,520 $ - $ 1,492,520 $ 81,293 $ 682,534 $ 2,256,347 Depreciation and amortization $ 13,170 $ 97,844 $ 111,014 $ 17,011 $ 47,072 $ 175,097 Income (loss) from operations 391,895 (808,575 ) (416,680 ) 114,801 141,826 (160,053 ) Other income (expense): (1,938 ) 41,630 39,692 - (2,424 ) 37,268 NET INCOME (LOSS) $ 389,957 $ (766,945 ) $ (376,988 ) $ 114,801 $ 139,402 $ (122,785 ) Segment Operations for the six Antimony Antimony Total Precious months ended June 30, 2019 USA Mexico Antimony Metals Zeolite Totals Total revenues $ 2,739,819 $ 473,592 $ 3,213,411 $ 85,050 $ 1,430,187 $ 4,728,648 Depreciation and amortization $ 21,755 $ 298,168 $ 319,923 $ 34,021 $ 92,602 $ 446,546 Income (loss) from operations (108,341 ) (1,432,098 ) (1,540,439 ) 51,029 345,225 (1,144,185 ) Other income (expense): (5,787 ) (36,338 ) (42,125 ) - (7,189 ) (49,314 ) NET INCOME (LOSS) $ (114,128 ) $ (1,468,436 ) $ (1,582,564 ) $ 51,029 $ 338,036 $ (1,193,499 ) Segment Operations for the six Antimony Antimony Total Precious months ended June 30, 2018 USA Mexico Antimony Metals Zeolite Totals Total revenues $ 3,174,333 $ - $ 3,174,333 $ 141,703 $ 1,373,240 $ 4,689,276 Depreciation and amortization $ 26,380 $ 297,366 $ 323,746 $ 34,021 $ 94,892 $ 452,659 Income (loss) from operations 589,934 (1,551,357 ) (961,423 ) 107,682 293,919 (559,822 ) Other income (expense): (2,716 ) (29,488 ) (32,204 ) - (5,199 ) (37,403 ) NET INCOME (LOSS) $ 587,218 $ (1,580,845 ) $ (993,627 ) $ 107,682 $ 288,720 $ (597,225 )

3. Income (Loss) Per Common S_3

3. Income (Loss) Per Common Share (Details) - shares	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Total possible dilution	2,001,005	2,001,005
Warrants
Total possible dilution	250,000	250,000
Convertible Preferred Stock
Total possible dilution	1,751,005	1,751,005

4. Revenue Recognition (Details

4. Revenue Recognition (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues	$ 2,272,283	$ 2,256,347	$ 4,728,648	$ 4,689,276
Antimony
Revenues	1,507,588	1,492,520	3,213,411	3,174,333
Zeolite
Revenues	704,172	682,534	1,430,187	1,373,240
Precious Metals
Revenues	60,523	81,293	85,050	141,703
United States
Revenues	1,819,707	1,878,244	3,928,276	4,125,935
Canada
Revenues	139,523	378,103	326,780	563,341
Mexico
Revenues	$ 313,053	$ 0	$ 473,592	$ 0

4. Revenue Recognition (Detai_2

4. Revenue Recognition (Details 1) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Sales to three largest customers	$ 1,098,095	$ 1,189,611	$ 2,376,886	$ 2,379,491
Total percentage of revenue	48.33%	52.70%	50.27%	50.70%
Accounts receivable of three largest customers	$ 176,190		$ 176,190		$ 214,769
Total percentage of accounts receivable				42.25%	49.00%
Mexichem Speciality Compounds
Sales to three largest customers	375,514	$ 669,103	1,059,525	$ 1,397,681
Nyacol Nanotechnologies
Sales to three largest customers	267,638	0	404,324	0
Kohler Corporation
Sales to three largest customers	454,943	334,778	913,037	651,550
Accounts receivable of three largest customers	123,106		123,106		$ 0
Ampacet Corporation
Sales to three largest customers	0	0	0	330,260
ZEO, Inc.
Sales to three largest customers	0	$ 185,730	0	$ 0
DanaMart
Accounts receivable of three largest customers	0		0		143,890
Axens
Accounts receivable of three largest customers	25,121		25,121		34,912
Earth Innovations
Accounts receivable of three largest customers	0		0		35,967
Nutreco Canada Inc.
Accounts receivable of three largest customers	$ 27,963		$ 27,963		$ 0

5. Inventories (Details)

5. Inventories (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Inventories	$ 723,688	$ 755,261
Antimony Oxide - Finished
Inventories	252,128	255,782
Antimony Metal
Inventories	0	8,127
Antimony Concentrates
Inventories	0	2,214
Antimony Ore
Inventories	201,543	257,067
Antimony
Inventories	453,671	523,190
Zeolite
Inventories	$ 270,017	$ 232,071

6. Accounts Receivable and Du_3

6. Accounts Receivable and Due to Factor (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Accounts receivable - non factored	$ 403,201	$ 421,867
Accounts receivable - factored with recourse	13,804	16,524
Accounts receivable - net	$ 417,005	$ 438,391

8. Note Payable to Bank (Detail

8. Note Payable to Bank (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Note payable to bank	$ 199,998	$ 183,917
Promissory note payable CD 48614
Note payable to bank	99,999	83,918
Promissory note payable CD 48615
Note payable to bank	$ 99,999	$ 99,999

9. Debt (Details)

9. Debt (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Total debt	$ 1,680,098	$ 1,733,190
Less current portion	(761,663)	(705,460)
Noncurrent portion	918,435	1,027,730
Zeo
Total debt	100,000	100,000
Cat Financial Services
Total debt	5,321	14,022
Cat Financial Services
Total debt	30,071	34,390
De Lage Landen Financial Services
Total debt	2,005	5,851
De Lage Landen Financial Services 1
Total debt	4,569	8,371
Phyllis Rice
Total debt	6,146	12,146
Soyatal Mine
Total debt	618,078	639,747
Guadalupe Mine
Total debt	$ 913,908	$ 918,663

9. Debt (Details 1)

9. Debt (Details 1)	Jun. 30, 2019USD ($)
2020	$ 761,663
2021	192,718
2022	151,821
2023	147,141
2024	123,472
Thereafter	303,283
Total	1,680,098
Principal Payment
2020	824,100
2021	240,956
2022	191,009
2023	179,735
2024	149,077
Thereafter	333,912
Total	1,918,789
Discount
2020	(62,437)
2021	(48,238)
2022	(39,188)
2023	(32,594)
2024	(25,605)
Thereafter	(30,629)
Total	$ (238,691)

10. Related Party Transactions

10. Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Chairman of the audit committee and compensation committee
Related party transactions	$ 0	$ 4,500	$ 0	$ 9,000
Chief Executive Officer
Related party transactions	$ 3,480	$ 5,064	$ 2,461	$ 4,555

13. Business Segments (Details)

13. Business Segments (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Properties, plants and equipment, net	$ 15,254,204	$ 15,227,172
Total assets	17,119,227	17,557,123
United States Antimony
Properties, plants and equipment, net	1,616,273	1,635,315
Total assets	2,171,811	2,199,694
Mexico Antimony
Properties, plants and equipment, net	11,779,305	11,660,769
Total assets	12,453,537	12,824,292
Subtotal Antimony
Properties, plants and equipment, net	13,395,577	13,296,084
Total assets	14,625,348	15,023,986
Precious Metals
Properties, plants and equipment, net	594,850	615,719
Total assets	594,850	615,719
Zeolite
Properties, plants and equipment, net	1,263,777	1,315,369
Total assets	$ 1,899,029	$ 1,917,418

13. Business Segments (Details

13. Business Segments (Details 1) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Capital expenditure	$ 161,010	$ 79,583	$ 473,578	$ 174,388
United States Antimony
Capital expenditure	1,368	0	2,713	0
Mexico Antimony
Capital expenditure	141,797	70,892	416,703	110,977
Subtotal Antimony
Capital expenditure	143,165	70,892	419,416	110,977
Precious Metals
Capital expenditure	6,398	0	13,152	40,988
Zeolite
Capital expenditure	$ 11,447	$ 8,691	$ 41,010	$ 22,423

13. Business Segments (Detail_2

13. Business Segments (Details 2) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Total revenues	$ 2,272,283	$ 2,256,347	$ 4,728,648	$ 4,689,276
Depreciation and amortization	223,273	175,097	446,546	452,659
Income (loss) from operations	(460,418)	(160,053)	(1,144,185)	(559,822)
Other income (expense)	(25,621)	37,268	(49,314)	(37,403)
NET INCOME (LOSS)	(486,039)	(122,785)	(1,193,499)	(597,225)
United States Antimony
Total revenues	1,194,535	1,492,520	2,739,819	3,174,333
Depreciation and amortization	10,878	13,170	21,755	26,380
Income (loss) from operations	(56,245)	391,895	(108,341)	589,934
Other income (expense)	(4,420)	(1,938)	(5,787)	(2,716)
NET INCOME (LOSS)	(60,665)	389,957	(114,128)	587,218
Mexico Antimony
Total revenues	313,053	0	473,592	0
Depreciation and amortization	149,083	97,844	298,168	297,366
Income (loss) from operations	(629,422)	(808,575)	(1,432,098)	(1,551,357)
Other income (expense)	(18,051)	41,630	(36,338)	(29,488)
NET INCOME (LOSS)	(647,473)	(766,945)	(1,468,436)	(1,580,845)
Subtotal Antimony
Total revenues	1,507,588	1,492,520	3,213,411	3,174,333
Depreciation and amortization	159,961	111,014	319,923	323,746
Income (loss) from operations	(685,667)	(416,680)	(1,540,439)	(961,423)
Other income (expense)	(22,471)	39,692	(42,125)	(32,204)
NET INCOME (LOSS)	(708,138)	(376,988)	(1,582,564)	(993,627)
Precious Metals
Total revenues	60,523	81,293	85,050	141,703
Depreciation and amortization	17,011	17,011	34,021	34,021
Income (loss) from operations	43,513	114,801	51,029	107,682
Other income (expense)	0	0	0	0
NET INCOME (LOSS)	43,513	114,801	51,029	107,682
Zeolite
Total revenues	704,172	682,534	1,430,187	1,373,240
Depreciation and amortization	46,301	47,072	92,602	94,892
Income (loss) from operations	181,736	141,826	345,225	293,919
Other income (expense)	(3,150)	(2,424)	(7,189)	(5,199)
NET INCOME (LOSS)	$ 178,586	$ 139,402	$ 338,036	$ 288,720